-
D122335-1gDaunorubicin HCl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM.A DNA intercalator which may suppress acute leukemia proliferation.
-
D122335-250mgDaunorubicin HCl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM.A DNA intercalator which may suppress acute leukemia proliferation.
-
D122335-50mgDaunorubicin HCl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM.A DNA intercalator which may suppress acute leukemia proliferation.
-
D343319-2.5mgDaunorubicin-13C,d3 is a rhodomycin related, anthracycline antibiotic.
-
D343319-250μgDaunorubicin-13C,d3 is a rhodomycin related, anthracycline antibiotic.
-
D344979-2.5mgDaunorubicinol Hydrochloride (mixture of diastereomers) is a Daunorubicin metabolite and is used as an antineoplastic. The compound complexes with DNA and Inhibits the synthesis of of DNA and RNA.
-
D329287-5mgDeacetylanisomycin is the core structure of a family of dihydroxypyrrolidines produced by several species of|Streptomyces|. Anisomycin esters are potent inhibitors of protein synthesis. While considered inactive, deacetylanisomycin is a potent
-
D351679-100mgDecarboxyl Ofloxacin is a degradation product of Oflaxacin.
-
D351679-10mgDecarboxyl Ofloxacin is a degradation product of Oflaxacin.
-
D351679-50mgDecarboxyl Ofloxacin is a degradation product of Oflaxacin.
-
D329297-0.5mgDecatromicin B is a tetronic acid isolated from a strain of|Actinomadura|in 1999. Decatromicin B is a potent antibiotic with activity against antibiotic sensitive and resistant strains such as MRSA. Lack of availability has hampered further
-
D337605-1mgDecladinose Roxithromycin is the inactive metabolite (M1) of Roxithromycin, and a Roxithromycin impurity B.